LivaNova
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, LivaNova sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).
LivaNova: 13 sponsored US clinical trials, 1 recruiting.
LivaNova sponsors 13 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 8 completed. 5 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Patients Implanted With a Pacemaker, with 1 trials.
Top-decile sponsor footprint
LivaNova ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
8 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
13 total, page 1 of 1
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
NCT03887715
Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
NCT04950894
The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes
NCT04753385
ANTHEM-HFrEF Pivotal Study
NCT03425422
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
NCT03446664
Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
NCT03529045
Mitroflow DL Post Approval Study- North America
NCT02351726
Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device
NCT02167789
Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications
NCT00560768
Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication
NCT00562107
Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers
NCT00531037
Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications
NCT00729703
Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease
NCT01170611
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 4 |
Therapeutic Areas
Where LivaNova enrollment is open (later-stage tilt)
1 recruiting of 13 indexed (8% open); 8 completed (62%).
Phase mix: 5 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Patients Implanted With a Pacemaker (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
LivaNova: open-pipeline peers nationwide
Peers matched on 13 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
LivaNova sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 13 trials (± recruiting share)
- Adaptimmune · 13 trials · 0% recruiting
- Agennix · 13 trials · 0% recruiting
- Akili Interactive Labs · 13 trials · 0% recruiting
- Alumis · 13 trials · 8% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Andrei Iagaru · 8% recruiting · 13 trials
- BioXcel Therapeutics · 8% recruiting · 13 trials
- Corporal Michael J. Crescenz VA Medical Center · 8% recruiting · 13 trials
- Fresenius Medical Care North America · 8% recruiting · 13 trials
Related
What to do with this LivaNova page
13 registered trials is a research-attention snapshot, not an endorsement of LivaNova or any single study.
- 1 of LivaNova's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Patients Implanted With a Pacemaker is the condition LivaNova studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Patients Implanted With a Pacemaker trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
LivaNova pipeline card: 13 registered trials from official public datasets.Report a data error.